Status: Recruiting
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
The purpose of this study is to evaluate the efficacy and safety of telitacicept in the treatment of generalized myasthenia gravis.
Participants needed: 180
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Vor BiopharmaUpdated: Jun 18, 2026Locations: 111
Eligibility criteria
Male or female patient aged ≥18 years at screening. [+4]
Patients have been diagnosed with any other autoimmune disease which can potenti... [+5]